Tech Company Financing Transactions
Morphotek Funding Round
Morphotek secured a $26 million Series C financing round on 2/18/2004. Backers included Forward Ventures, Burrill & Company and CB Health Ventures.
Transaction Overview
Company Name
Announced On
2/18/2004
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series C
Investors
Forward Ventures (Lead Investor) (Ivor Royston)
Proceeds Purpose
The funds raised in the Series C round will be used primarily to advance the development of Morphotek's therapeutic antibodies through preclinical testing and development for clinical evaluation.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
210 Welsh Pool Road
Exton, PA 19341
USA
Exton, PA 19341
USA
Phone
Website
Email Address
Not Recorded
Overview
Morphotek is a biopharmaceutical company developing therapeutic monoclonal antibodies through the use of a proprietary human antibody technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Nicolaides
Browse more venture capital transactions:
Prev: 2/17/2004: TestQuest venture capital transaction
Next: 2/18/2004: Inovys venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs